PD-L1 t-haNK

Trials studying PD-L1 t-haNK

• phase2N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastomaactive not recruitingn=34
• phase1QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancerscompletedn=16
• phase2PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCCrecruitingn=25
• phase2QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitorsactive not recruitingn=40
• phase2Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Canceractive not recruitingn=328
• phase2A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapiesterminatedn=3